161 related articles for article (PubMed ID: 21166992)
1. Impact of von Willebrand disease on health-related quality of life in a pediatric population.
de Wee EM; Fijnvandraat K; de Goede-Bolder A; Mauser-Bunschoten EP; Eikenboom JC; Brons PP; Smiers FJ; Tamminga R; Oostenbrink R; Raat H; van der Bom JG; Leebeek FW;
J Thromb Haemost; 2011 Mar; 9(3):502-9. PubMed ID: 21166992
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life among adult patients with moderate and severe von Willebrand disease.
de Wee EM; Mauser-Bunschoten EP; Van Der Bom JG; Degenaar-Dujardin ME; Eikenboom HC; Fijnvandraat K; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Raat H; Leebeek FW;
J Thromb Haemost; 2010 Jul; 8(7):1492-9. PubMed ID: 20345712
[TBL] [Abstract][Full Text] [Related]
3. Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.
van Galen KPM; Sanders YV; Vojinovic U; Eikenboom J; Cnossen MH; Schutgens REG; van der Bom JG; Fijnvandraat K; Laros-Van Gorkom BAP; Meijer K; Leebeek FWG; Mauser-Bunschoten EP;
Haemophilia; 2015 May; 21(3):e185-e192. PubMed ID: 25854528
[TBL] [Abstract][Full Text] [Related]
4. Relative contributions of bleeding scores and iron status on health-related quality of life in von Willebrand disease: a cross-sectional study.
Xu Y; Deforest M; Grabell J; Hopman W; James P
Haemophilia; 2017 Jan; 23(1):115-121. PubMed ID: 27611464
[TBL] [Abstract][Full Text] [Related]
5. Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype.
Kempers EK; van Kwawegen CB; de Meris J; Schols SEM; van Galen KPM; Meijer K; Cnossen MH; van der Bom JG; Fijnvandraat K; Eikenboom J; Atiq F; Leebeek FWG;
Haemophilia; 2022 Mar; 28(2):278-285. PubMed ID: 34964530
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease.
Abdul S; Boender J; Malfliet JJMC; Eikenboom J; Fijn van Draat K; Mauser-Bunschoten EP; Meijer K; de Meris J; Laros-van Gorkom BAP; van der Bom JG; Leebeek FWG; Rijken DC; Uitte de Willige S;
Haemophilia; 2017 May; 23(3):437-443. PubMed ID: 28306198
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand disease and aging: an evolving phenotype.
Sanders YV; Giezenaar MA; Laros-van Gorkom BA; Meijer K; van der Bom JG; Cnossen MH; Nijziel MR; Ypma PF; Fijnvandraat K; Eikenboom J; Mauser-Bunschoten EP; Leebeek FW;
J Thromb Haemost; 2014 Jul; 12(7):1066-75. PubMed ID: 24750783
[TBL] [Abstract][Full Text] [Related]
8. Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleeding.
Sanders YV; Fijnvandraat K; Boender J; Mauser-Bunschoten EP; van der Bom JG; de Meris J; Smiers FJ; Granzen B; Brons P; Tamminga RY; Cnossen MH; Leebeek FW;
Am J Hematol; 2015 Dec; 90(12):1142-8. PubMed ID: 26375306
[TBL] [Abstract][Full Text] [Related]
9. Utility of a Paediatric Bleeding Questionnaire as a screening tool for von Willebrand disease in apparently healthy children.
Mittal N; Naridze R; James P; Shott S; Valentino LA
Haemophilia; 2015 Nov; 21(6):806-11. PubMed ID: 25982122
[TBL] [Abstract][Full Text] [Related]
10. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
[TBL] [Abstract][Full Text] [Related]
11. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.
de Wee EM; Sanders YV; Mauser-Bunschoten EP; van der Bom JG; Degenaar-Dujardin ME; Eikenboom J; de Goede-Bolder A; Laros-van Gorkom BA; Meijer K; Hamulyák K; Nijziel MR; Fijnvandraat K; Leebeek FW;
Thromb Haemost; 2012 Oct; 108(4):683-92. PubMed ID: 22918553
[TBL] [Abstract][Full Text] [Related]
12. Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
De Wee EM; Klaij K; Eikenboom HC; Van Der Bom JG; Fijnvandraat K; Laros-Van Gorkom BA; Mauser-Bunschoten EP; Meijer K; Goverde G; Van Der Linden PW; Rijken DC; Leebeek FW;
Haemophilia; 2012 May; 18(3):444-51. PubMed ID: 21910790
[TBL] [Abstract][Full Text] [Related]
13. Sports participation and physical activity in patients with von Willebrand disease.
Atiq F; Mauser-Bunschoten EP; Eikenboom J; van Galen KPM; Meijer K; de Meris J; Cnossen MH; Beckers EAM; Laros-van Gorkom BAP; Nieuwenhuizen L; van der Bom JG; Fijnvandraat K; Leebeek FWG;
Haemophilia; 2019 Jan; 25(1):101-108. PubMed ID: 30427095
[TBL] [Abstract][Full Text] [Related]
14. Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study.
Vangenechten I; Smejkal P; Zapletal O; Michiels JJ; Berneman Z; Zavrelova J; Blatný J; Penka M; Gadisseur A
Thromb Haemost; 2019 Apr; 119(4):594-605. PubMed ID: 30722078
[TBL] [Abstract][Full Text] [Related]
15. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
Tosetto A; Rodeghiero F; Castaman G; Goodeve A; Federici AB; Batlle J; Meyer D; Fressinaud E; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
J Thromb Haemost; 2006 Apr; 4(4):766-73. PubMed ID: 16634745
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of bleeding phenotype in PT-VWD compared to type 2B VWD using an electronic bleeding questionnaire.
Kaur H; Ozelo M; Scovil S; James PD; Othman M
Clin Appl Thromb Hemost; 2014 Nov; 20(8):765-71. PubMed ID: 25063765
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire.
Biss TT; Blanchette VS; Clark DS; Bowman M; Wakefield CD; Silva M; Lillicrap D; James PD; Rand ML
J Thromb Haemost; 2010 May; 8(5):950-6. PubMed ID: 20136710
[TBL] [Abstract][Full Text] [Related]
18. HRQoL and psychosocial aspects of burden on caregivers to children with moderate or severe von Willebrand disease.
Olsson A; Petrini P; Engman Grahn E; Myrin Westesson L
Haemophilia; 2023 Jul; 29(4):1056-1062. PubMed ID: 37291684
[TBL] [Abstract][Full Text] [Related]
19. Health status and health-related quality of life associated with von Willebrand disease.
Barr RD; Sek J; Horsman J; Furlong W; Saleh M; Pai M; Walker I
Am J Hematol; 2003 Jun; 73(2):108-14. PubMed ID: 12749012
[TBL] [Abstract][Full Text] [Related]
20. Clinical, economic, and health-related quality of life burden associated with von Willebrand disease in adults and children: Systematic and targeted literature reviews.
Castaman G; Katsarou O; Jansen N; Santos S; Escolar G; Berntorp E
Haemophilia; 2023 Mar; 29(2):411-422. PubMed ID: 36097135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
